Jay Venkatesan, Director at Serina Therapeutics, Inc. (SER), bought 589 shares at $1.78 ($1K) on 2026-05-22, disclosed to the SEC on 2026-06-22.
Open-market purchase of $1k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| ANGN | BUY | 2021-12-29 | $1.5M | — | Filing → |
| ANGN | BUY | 2021-12-22 | $9K | — | Filing → |
| ANGN | BUY | 2021-12-20 | $177K | — | Filing → |